Glycosylation Engineering of Biopharmaceuticals [E-Book] : Methods and Protocols / edited by Alain Beck
Glyco-engineering is being developed as a method to control the composition of carbohydrates and to enhance the pharmacological properties of monoclonal antibodies (mAbs) and other proteins. In Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols, experts in the field provide read...
Saved in:
Full text |
|
Personal Name(s): | Beck, Alain |
Imprint: |
Totowa, NJ :
Humana Press,
2013
|
Physical Description: |
XV, 355 p. 111 illus., 45 illus. in color. digital. |
Note: |
englisch |
ISBN: |
9781627033275 |
DOI: |
10.1007/978-1-62703-327-5 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
Methods in molecular biology, methods and protocols ;
988 |
Subject (LOC): |
LEADER | 04748nam a22003735i 4500 | ||
---|---|---|---|
001 | 978-1-62703-327-5 | ||
003 | Springer | ||
008 | 130321s2013 xxu| s |||| 0|eng d | ||
020 | |a 9781627033275 | ||
024 | 7 | |a 10.1007/978-1-62703-327-5 |2 doi | |
035 | |a (Sirsi) a376186 | ||
035 | |a i9781627033275 | ||
041 | |a eng | ||
082 | 0 | 4 | |a 615 |2 23 |
245 | 1 | 0 | |a Glycosylation Engineering of Biopharmaceuticals |h [E-Book] : |b Methods and Protocols / |c edited by Alain Beck |
264 | 1 | |a Totowa, NJ : |b Humana Press, |c 2013 |e (Springer LINK) | |
300 | |a XV, 355 p. 111 illus., 45 illus. in color. |b digital. | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | |a Methods in molecular biology, methods and protocols ; |v 988 | ||
500 | |a englisch | ||
505 | 0 | |a Engineering of Therapeutic and Diagnostic O-Glycans on Recombinant Mucin-Type Immunoglobulin Fusion Proteins Expressed in CHO Cells -- Engineering a Human-Like Glycosylation to Produce Therapeutic Glycoproteins Based on 6-Linked Sialylation in CHO Cells -- Glycoengineered Pichia-Based Expression of Monoclonal Antibodies -- N-Glycosylation Humanization for Production of Therapeutic Recombinant Glycoproteins in Saccharomyces cerevisiae -- Engineering the Baculovirus Genome to Produce Galactosylated Antibodies in Lepidopteran Cells -- Nano LC Chips MS/MS for the Characterization of N-Glycopeptides Generated from Trypsin Digestion of a Monoclonal Antibody -- Cetuximab Fab and Fc N-Glycan Fast Characterization Using IdeS Digestion and Liquid Chromatography Coupled to Electrospray Ionization Mass Spectrometry -- Therapeutic Antibody Glycosylation Analysis: A Contract Research Organization Perspective in the Frame of Batch Release or Comparability Support -- Mass Spectrometric Analysis of O-Linked Oligosaccharides from Various Recombinant Expression Systems -- Assessing Fc Glycan Heterogeneity of Therapeutic Recombinant Monoclonal Antibodies Using NP-HPLC -- Application of Capillary Electrophoresis in Glycoprotein Analysis -- Characterization of Glycoprotein Biopharmaceutical Products by Caliper LC90 CE-SDS Gel Technology -- Hydrophobic Interaction Chromatography to Analyze Glycoproteins -- Lectin Glycoprofiling of Recombinant Therapeutic Interleukin-7 -- Analysis of Monoclonal Antibodies by Sedimentation Velocity Analytical Ultracentrifugation -- Noncovalent Mass Spectrometry for the Characterization of Antibody/Antigen Complexes -- Conformational Analysis of Recombinant Monoclonal Antibodies with Hydrogen/Deuterium Exchange Mass Spectrometry -- Epitope Mapping of Antibodies by Mass Spectroscopy: A Case Study -- Evaluation of Antibody-Dependent Cell Cytotoxicity Using Lactate Deshydrogenase (LDH) Measurement -- Evaluation of Complement Dependent Cytotoxicity Using ATP Measurement and C1q / C4b Binding -- Capture of the Human IgG1 Antibodies by Protein A for the Kinetic Study of h-IgG / FcgR Interaction Using SPR-Based Biosensor Technology -- Mass Spectrometry Protocol for the Absolute Quantification of a Monoclonal Antibody in Serum with Immunopurification. | |
520 | |a Glyco-engineering is being developed as a method to control the composition of carbohydrates and to enhance the pharmacological properties of monoclonal antibodies (mAbs) and other proteins. In Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols, experts in the field provide readers with production and characterization protocols of glycoproteins and glyco-engineered biopharmaceuticals with a focus on mAbs. The volume is divided in four complementary parts dealing with glyco-engineering of therapeutic proteins, glycoanalytics, glycoprotein complexes characterization, and PK/PD assays for therapeutic antibodies. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols serves as an ideal guide for scientists striving to push forward the exciting field of engineered biopharmaceuticals. | ||
650 | 0 | |a Biochemical engineering. | |
650 | 0 | |a Medicine. | |
650 | 0 | |a Toxicology. | |
700 | 1 | |a Beck, Alain | |
856 | |u https://link.springer.com/book/10.1007/978-1-62703-327-5 |z Volltext | ||
908 | |a SpringerProtocols | ||
915 | |a zzwFZJ3 | ||
932 | |a Springer Protocols (Springer-12345) | ||
596 | |a 1 | ||
949 | |a XX(376186.1) |w AUTO |c 1 |i 376186-1001 |l ELECTRONIC |m ZB |r N |s Y |t E-BOOK |u 22/4/2013 |x ZB-L |z UNKNOWN |1 ONLINE |o .STAFF. NEL |